Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2025-01-03T14:08:35.286Z Has data issue: false hasContentIssue false

10 - Human Susceptibility to Visceral Leishmaniasis (Leishmania donovani) and to Schistosomiasis (Schistosoma mansoni) Is Controlled by Major Genetic Loci

Published online by Cambridge University Press:  10 August 2009

By
A. Dessein ,
B. Bucheton ,
L. Argiro ,
N. M. A. Elwali ,
V. Rodrigues ,
C. Chevillard ,
S. Marquet ,
H. Dessein ,
S. H. El-Safi  and
L. Abel
Edited by
Krishna R. Dronamraju
A. Dessein
Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
B. Bucheton
Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
L. Argiro
Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
N. M. A. Elwali
Affiliation:
Institute of Nuclear Medicine and Molecular Biology, University of Gezira, Wad Medani, Sudan
V. Rodrigues
Affiliation:
Laboratory of Immunology, University of Medicine, Triangulo Miniero, Uberaba, Brazil
C. Chevillard
Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
S. Marquet
Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
H. Dessein
Affiliation:
Immunology and Genetics of Parasitic Diseases, INSERM, U. 399, Marseille, France
S. H. El-Safi
Affiliation:
Institute for Tropical Medicine, PO Box 1304, Khartoum, Sudan
L. Abel
Affiliation:
Laboratory of Human Genetics of Infectious Diseases, INSERM, U. 550, Paris, France
Krishna R. Dronamraju
Affiliation:
Foundation for Genetic Research, Houston, Texas
Get access

Summary

SUSCEPTIBILITY TO SEVERE DISEASE DURING AN OUTBREAK OF VISCERAL LEISHMANIASIS IN A SUDANESE VILLAGE

Visceral leishmaniasis (VL) is caused by protozoan parasites of the Leishmania genus that are transmitted to humans by infected sandflies (Figure 10.1a). Parasites rapidly invade host phagocytes and multiply inside phagolysosomes. Clinical disease is primarily due to the uncontrolled multiplication of the parasite in many organs including the spleen and the liver; clinical symptoms include recurrent fever, considerable splenomegaly, hepatomegaly, and adenopathy (1). Death is certain if the patient is left untreated. Violent outbreaks of VL have occurred in regions of eastern Africa (2) (Kenya, Sudan) and in India (Bihar). VL is endemic in South America and in the Mediterranean basin. VL is caused by three Leishmania species: Leishmania donovani, L. chagasi/infantum, and L. archibaldi (L. donovani being the most pathogenic) (3). To identify the principal risk factors in VL, we carried out a five-year longitudinal study on 1,600 subjects from a village located on the Sudanese–Ethiopian border. The study was initiated in 1995 when the number of VL cases had just begun to rise in the village (4). Within five years, 28% of the population had been affected by VL. Most of these VL patients were treated and cured. Unfortunately, a small percentage either failed to respond to treatment or were not treated because of the difficulties involved in reaching them during the rainy season.

Type
Chapter
Information
Infectious Disease and Host-Pathogen Evolution , pp. 241 - 262
Publisher: Cambridge University Press
Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dessein, A J, Chevillard, C, Marquet, S, Henri, S, Hillaire, D, Dessein, H. 2001. Genetics of parasitic infections. Drug Metab. Dispos. 29(4 Pt 2): 484–8Google ScholarPubMed
Seaman, J, Mercer, A J, Sondorp, E. 1996. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: Course and impact from 1984 to 1994. Int. J. Epidemiol. 25(4): 862–71CrossRefGoogle ScholarPubMed
Desjeux P. The increase in risk factors for leishmaniasis worldwide. 2001. Trans. R. Soc. Trop. Med. Hyg. 95: 239–43
El-Safi, S H, Bucheton, B, Kheir, M M, Musa, H A, El-Obeid, M, Hammad, A, and Dessein, A. 2002. Epidemiology of visceral leishmaniasis in Atbara River area, Eastern Sudan: The outbreak of Barbar El Fugara village (1996–1997). Microb. Infect. 14: 1439–47CrossRefGoogle Scholar
Bucheton B, El-Safi S H, Hammad A, Kheir M M, Eudes N, Mergani A, and Dessein A. 2002. Anti-Leishmania antibodies in an outbreak of visceral leishmaniasis in Eastern Sudan: High antibody responses occur in resistant subjects and are not predictive of disease. Trans. R. Trop. Med. Hyg. (in press)
Lambert, J, and 7 colleagues. 2002. The sand fly fauna in the visceral leishmaniasis focus of Gedaref (Atbara River area, Eastern Sudan). Ann. Trop. Med. Parasitol. 96(6): 631–6CrossRefGoogle Scholar
Bucheton, B, Kheir, M M, El-Safi, S H, Hammad, A, Mergani, A, Mary, C, Abel, L, and Dessein, A. 2002. The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in Eastern Sudan. Microb. Infect. 14: 1449–57CrossRefGoogle Scholar
Bradley, D J, Taylor, B A, Blackwell, J, Evans, E P, Freeman, J. 1979. Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin. Exp. Immunol. 37(1): 7–14Google ScholarPubMed
Blackwell, J M. 1996. Genetic susceptibility to leishmanial infections: Studies in mice and man. Parasitology 112(Suppl): S67–S74Google ScholarPubMed
Vidal, S and 9 colleagues. 1995. The Ity/Lsh/Bcg locus: Natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182(3): 655–66CrossRefGoogle ScholarPubMed
Blackwell, J, Freeman, J, Bradley, D. 1980. Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature 283(5742): 72–4CrossRefGoogle ScholarPubMed
Searle, S, Bright, N A, Roach, T I, Atkinson, P G, Barton, C H, Meloen, R H, and colleagues. 1998. Localisation of Nramp1 in macrophages: Modulation with activation and infection. J. Cell. Sci. 111(Pt 19): 2855–66Google ScholarPubMed
Biggs, T E, Baker, S T, Botham, M S, Dhital, A, Barton, C H, Perry, V H. 2001. Nramp1 modulates iron homoeostasis in vivo and in vitro: Evidence for a role in cellular iron release involving de-acidification of intracellular vesicles. Eur. J. Immunol. 31(7): 2060–703.0.CO;2-L>CrossRefGoogle ScholarPubMed
Blackwell, J M, Goswami, T, Evans, C A, Sibthorpe, D, Papo, N, White, J K, and 5 colleagues. 2001. SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol. 3(12): 773–84CrossRefGoogle ScholarPubMed
Liu, J, Fujiwara, T M, Buu, N T, Sanchez, F O, Cellier, M, Paradis, A J, and colleagues. 1995. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am. J. Hum. Genet. 56(4): 845–53Google ScholarPubMed
Bellamy, R, Ruwende, C, Corrah, T, McAdam, K P, Whittle, H C, Hill, A V. 1998. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338(10): 640–4CrossRefGoogle ScholarPubMed
Abel, L, Sanchez, F O, Oberti, J, Thuc, N V, Hoa, L V, Lap, V D, and colleagues. 1998. Susceptibility to leprosy is linked to the human NRAMP1 gene. J. Infect. Dis. 177(1): 133–45CrossRefGoogle ScholarPubMed
Greenwood, C M, Fujiwara, T M, Boothroyd, L J, Miller, M A, Frappier, D, Fanning, E A, and colleagues. 2000. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am. J. Hum. Genet. 67(2): 405–16CrossRefGoogle Scholar
Searle, S, Blackwell, J M. 1999. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J. Med. Genet. 36(4): 295–9Google ScholarPubMed
Bucheton, B, Abel, L, Kheir, M M, Mirghani, A, El-Safi, S, Chevillard, C, Dessein, A. 2003. Genetic control of visceral leishmaniasis in a Sudanese population: Candidate gene testing indicates a linkage to the NRAMP1 gene. Genes. Immun. 4: 104–109CrossRefGoogle Scholar
Abel, L, Muller-Myhsok, B. 1998. Robustness and power of the maximum-likelihood-binomial and maximum-likelihood-score methods, in multipoint linkage analysis of affected-sibship data. Am. J. Hum. Genet. 63(2): 638–47CrossRefGoogle ScholarPubMed
Xu, J, Meyers, D A, Ober, C, Blumenthal, M N, Mellen, B, Barnes, K C, and 9 colleagues. 2001. Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: Collaborative study on the genetics of asthma. Am. J. Hum. Genet. 68(6): 1437–46CrossRefGoogle Scholar
Lichtenberg, F. 1962. Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse. Am. J. Pathol. 41: 711–31Google Scholar
Warren, K S, Domingo, E O, Cowan, R B. 1967. Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am. J. Pathol. 51(5): 735–56Google ScholarPubMed
Butterworth, A E, Capron, M, Cordingley, J S, Dalton, P R, Dunne, D W, Kariuki, H C, and 9 colleagues. 1985. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans. R. Soc. Trop. Med. Hyg. 79(3): 393–408CrossRefGoogle ScholarPubMed
Dessein, A J, Begley, M, Demeure, C, Caillol, D, Fueri, J, dos Reis, M G, and 3 colleagues. 1988. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J. Immunol. 140(8): 2727–36Google ScholarPubMed
Abel, L, Dessein, A. 1991. Genetic predisposition to high infections in an endemic area of Schistosoma mansoni [editorial]. Rev. Soc. Bras. Med. Trop. 24(1): 1–3CrossRefGoogle Scholar
Dessein, A J, Couissinier, P, Demeure, C, Rihet, P, Kohlstaedt, S, Carneiro-Carvalho, D, and 4 colleagues. 1992. Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni. Immunol. Invest. 21(5): 423–53CrossRefGoogle ScholarPubMed
Hagan, P, Blumenthal, U J, Dunn, D, Simpson, A J, Wilkins, H A. 1991. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349(6306): 243–5CrossRefGoogle ScholarPubMed
Rihet, P, Demeure, C E, Bourgois, A, Prata, A, Dessein, A J. 1991. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21(11): 2679–86CrossRefGoogle ScholarPubMed
Couissinier, P, Dessein, A J. 1995. Schistosoma-specific helper T cell from subjects resistant to infection by Schistosoma mansoni are ThO/2. Euro. J. Immunol. 25: 2295–302CrossRefGoogle Scholar
Rodriguez, V, Piper, K, Couissinier-Paris, P, Bacelar, O, Dessein, H, Dessein, A J. 1999. Genetic control of Schistosome infections by SM1 locus of the 5q31-q33 region is linked to differentition of type 2 helper T lymphocytes. Infect. Immun.67, 4689–92Google Scholar
Rihet, P, Demeure, C E, Dessein, A J, Bourgois, A. 1992. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area. Eur. J. Immunol. 22(8): 2063–70CrossRefGoogle ScholarPubMed
Demeure, C E, Rihet, P, Abel, L, Ouattara, M, Bourgois, A, Dessein, A J. 1993. Resistance to Schistosoma mansoni in humans: Influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J. Infect. Dis. 168(4): 1000–8CrossRefGoogle ScholarPubMed
Abel, L, Demenais, F, Prata, A, Souza, A E, Dessein, A. 1991. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni [see comments]. Am. J. Hum. Genet. 48(5): 959–70Google Scholar
Marquet, S, Abel, L, Hillaire, D, Dessein, H, Kalil, J, Feingold, J, and 2 colleagues. 1996. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14(2): 181–4CrossRefGoogle ScholarPubMed
Muller-Myhsok, B, Stelma, F F, Guisse-Sow, F, Muntau, B, Thye, T, Burchard, G D, and 2 colleagues. 1997. Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni [letter; comment]. Am. J. Hum. Genet. 61(2): 452–4CrossRefGoogle Scholar
Marsh, D G, Neely, J D, Breazeale, D R, Ghosh, B, Freidhoff, L R, Ehrlich-Kautzky, E, and colleagues. 1994. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264(5162): 1152–6CrossRefGoogle ScholarPubMed
Martinez, F D, Solomon, S, Holberg, C J, Graves, P E, Baldini, M, Erickson, R P. 1998. Linkage of circulating eosinophils markers on chromosome 5q. Am. J. Respir. Crit. Care Med. 158: 1739–44CrossRefGoogle ScholarPubMed
Rioux, J D, Stone, V A, Daly, M J, Cargill, M, Green, T, Nguyen, H, and colleagues. 1998. Familial eosinophiliz maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am. J. Hum. Genet. 63: 1086–94CrossRefGoogle ScholarPubMed
Warren, K S. 1977. Modulation of immunopathology and disease in schistosomiasis. Am. J. Trop. Med. Hyg. 26(6 Pt 2): 113–9CrossRefGoogle ScholarPubMed
Chensue, S W, Warmington, K S, Ruth, J, Lincoln, P M, Kunkel, S L. 1994. Cross-regulatory role of interferon-gam ma (IFN-gamma), IL-4 and IL-10 in schistosome egg granuloma formation: The in vivo regulation of activity and inflammation. Clin. Exp. Immunol. 98(3): 395–400CrossRefGoogle Scholar
Wynn, T A, Morawetz, R, Scharton-Kersten, T, Hieny, S, Morse, H C 3rd, Kuhn, R, and colleagues. 1997. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J. Immunol. 159(10): 5014–23Google Scholar
Grimaud, J A, Borojevic, R. 1977. Chronic human schistosomiasis mansoni. Pathology of the Disse's space. Lab. Invest. 36(3): 268–73Google ScholarPubMed
Gressner, A M, Bachem, M G. 1995. Molecular mechanisms of liver fibrogenesis – A homage to the role of activated fat-storing cells. Digestion 56(5): 335–46CrossRefGoogle ScholarPubMed
Poli, G. 2000. Pathogenesis of liver fibrosis: Role of oxidative stress. Mol. Aspects Med. 21(3): 49–98CrossRefGoogle ScholarPubMed
Hoffmann, K F, Cheever, A W, Wynn, T A. 2000. IL-10 and the dangers of immune polarization: Excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 164(12): 6406–16CrossRefGoogle ScholarPubMed
Jimenez, S A, Freundlich, B, Rosenbloom, J. 1984. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J. Clin. Invest. 74(3): 1112–6CrossRefGoogle ScholarPubMed
Duncan, M R, Berman, B. 1985. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J. Exp. Med. 162(2): 516–27CrossRefGoogle Scholar
Czaja, M J, Weiner, F R, Eghbali, M, Giambrone, M A, Eghbali, M, Zern, M A. 1987. Differential effects of gamma-interferon on collagen and fibronectin gene expression. J. Biol. Chem. 262(27): 13,348–51Google ScholarPubMed
Czaja, M J, Weiner, F R, Takahashi, S, Giambrone, M A, Meide, P H, Schellekens, H, and 2 colleagues. 1989. Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 10(5): 795–800CrossRefGoogle ScholarPubMed
Rockey, D C, Chung, J J. 1994. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis. J. Invest. Med. 42(4): 660–70Google ScholarPubMed
Mallat, A, Preaux, A M, Blazejewski, S, Rosenbaum, J, Dhumeaux, D, Mavier, P. 1995. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 21(4): 1003–10CrossRefGoogle ScholarPubMed
Roberts, A B, Sporn, M B, Assoian, R K, Smith, J M, Roche, N S, Wakefield, L M, and 2 colleagues. 1986. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83(12): 4167–71CrossRefGoogle ScholarPubMed
Tiggelman, A M, Boers, W, Linthorst, C, Sala, M, Chamuleau, R A. 1995. Collagen synthesis by human liver (myo)fibroblasts in culture: Evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma. J. Hepatol. 23(3): 307–17Google ScholarPubMed
Tamai, K, Ishikawa, H, Mauviel, A, Uitto, J. 1995. Interferon-gamma coordinately upregulates matrix metalloprotease (MMP)-1 and MMP-3, but not tissue inhibitor of metalloproteases (TIMP), expression in cultured keratinocytes. J. Invest. Dermatol. 104(3): 384–90CrossRefGoogle Scholar
Mohamed-Ali, Q, Elwali, N E, Abdelhameed, A A, Mergani, A, Rahoud, S, Elagib, K E, and 3 colleagues. 1999. Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: Evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J. Infect. Dis. 180(4): 1298–306CrossRefGoogle ScholarPubMed
Henri, S, Chevillard, C, Mergani, A, Paris, P, Gaudart, J, Camilla, C, and colleagues. 2002. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J. Immunol. 169(2): 929–36CrossRefGoogle Scholar
Dessein, A J, Hillaire, D, Elwali, E N M A, Marquet, S, Mohamed-Ali, Q, Mirghani, A, and colleagues. 1999. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-g receptor gene. Am. J. Hum. Genet. 68: 709–21CrossRefGoogle Scholar
Salam, E A, Ishaac, S, Mahmoud, A A. 1979. Histocompatibilty-linked susceptibility for hepatosplenomegaly in human schistosomiasis mansoni. J. Immunol. 123(4): 1829–31Google ScholarPubMed
Abaza, H, Asser, L, el Sawy, M, Wasfy, S, Montaser, L, Hagras, M, and 3 colleagues. 1985. HLA antigens in schistosomal hepatic fibrosis patients with haematemesis. Tissue Antigens 26(5): 307–9CrossRefGoogle ScholarPubMed
Abdel-Wahab, M F, Esmat, G, Narooz, S I, Yosery, A, Struewing, J P, Strickland, G T. 1990. Sonographic studies of school children in a village endemic for Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 84(1): 69–73CrossRefGoogle Scholar
Secor, W E, del Corral, H, dos Reis, M G, Ramos, E A, Zimon, A E, Matos, E P, and colleagues. 1996. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. J. Infect. Dis. 174(5): 1131–5CrossRefGoogle ScholarPubMed
Casanova, J L, Abel, L. 2002. Genetic dissection of immunity to mycobacteria: The human model. Annu. Rev. Immunol. 20: 581–620.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×